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The Original Benefactor 
John P. McGovern, M.D. 1921 - 2007 
When I became Dean of GSBS mid 1999, I did not 
know Dr. McGovern, but knew of his serious commitment 
to biomedical research and education long before then. 
He was a great supporter of education at the Graduate 
School, e.g., McGovern Teaching Awards and McGovern 
Poster Awards, and an equally strong supporter of research 
at many institutions in the Texas Medical Center. I knew 
of his clinical acumen since my wife was a patient at his 
al lergy clinic and was a great admirer of his before we ever 
met. 
Early in 20011 received a phone call from Dr. McGovern's office asking 
if I would meet with him at his home. When I arrived he was cordial and we 
exchanged brief pleasantries- he then said very nonchalantly, "We can keep on 
throwing posies at each other, or you can tell me what your school needs." 1 
responded that we had one overriding need - to recruit and support outstanding 
and capable students from a variety of backgrounds. He asked how he could help. 
He wanted to honor me with a professorship. Together we strategized how the 
first endowed professorship in the biomedical sciences would be held by me and 
each succeeding dean at GSBS with the income targeted ro provide student re-
cruitment funds and scholarships for what would best achieve that goal. He 
asked where to send the check, and I was immediately certain that he had done a 
great deal of homework about our School (and perhaps its new Dean!) long be-
fore I walked through his door that afternoon. 
I made it a point to send him notes in subsequent years thanking him for 
his support, sometimes with pictures of the students who benefited from the en-
dowment income, and every year he sent a gift to add to the endowment. Sup-
porting students and their research training was a never-ending process for Dr. 
McGovern throughout his life and will remain as his legacy at GSBS. 
George Stancel, Ph.D. 
Dr. John P. McGovern was the first and continuously generous finan-
cial donor to the Graduate School of Biomedical Sciences. I had contact with 
him almost from the first day I walked in the door of the GSBS in 1966. He was 
also my allergist. He was the quintessential Southern Gentleman and was com-
mitted to personally preserving the "History of Medicine." The GSBS bestowed 
the title of Professor of the History of Medicine to him which he often listed 
among his credits. He was a major force in overseeing the preservation of appro-
priate books and documents detailing how medical training and practice evolved. 
l had many and always positive contacts with him over the years. He 
always signed his formal letters to me (usually when he sent in his annual dona-
tion) "Jack." 
' I always addressed him in correspondence and called him "Dr. 
McGovern." In the many articles written about him in the newspapers following 
his death, one said that he always insisted that his friends call him "Jack." That 
pleased me more than I can express in this tribute. 
Melva Ramsay 
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Candidacy and Time to Degree -
On the way to achieving a 
Ph.D. in the biomedical sciences we 
train our students in critical think-
ing and sharpen their intellectual 
prowess as they study and develop 
research projects for the ultimate 
purpose of making new key discov-
eries. Most in my generation re-
ceived our Ph.D.'s in 4-5 years, of-
ten closer to four. At GSBS that 
figure is now approximately 5 'l2 
years on average and even ap-
proaching 6 for certain programs. 
This is well below the na tional 
norm (7 years or more for biologi-
cal sciences depending upon whose 
statistics you use and the specific 
discipline). Even so, it is in 
everyone's best interests to ask 
whether it can be decreased with-
out sacrificing the quality of the stu-
dents' education. 
If we consider the two main 
phases of doctoral training, pre- and 
post-candidacy, there arc things we 
might do in both. Better mentoring, 
increasing expectations of faculty 
(with commensurate recognition), 
and more clearly defined expecta-
tions for faculty and students wou ld 
help in both phases, but the time 
spent in the post-candidacy phase 
is likely to remain the more vari-
able and difficult to prescribe. On 
the other hand, are there other 
things we might do to decrease the 
time it takes studen ts to progress to 
candidacy, i.e., to be ready to un-
dertake independent dissertation 
research? 
Is Less More? 
A place to start might be 
the primary purpose of the candi-
dacy exam. If the goal is to assess 
whether a student is capable of un-
dertaking independent research and 
ready to do so, is it necessary for 
the student to genera te a large 
amount of data for their exam pro-
posal? If we used options such as 
writing a proposal on a topic other 
than one's own research or reduc-
ing the amount of preliminary data 
(real or perceived) that students and 
mentors think they need, could we 
mandate a shorter, invariant amount 
of time such as two years to pass the 
candidacy exam. We should always 
allow exceptions for reasons such as 
entrance deficiencies, health prob-
lems, etc., but the real question is 
whether two years is sufficient for 
most students if we have proper 
admission's criteria? These is not a 
simple issue, but the point is to 
think about how we might shorten 
the time to candidacy so that quali-
fied students could begin the disser-
tation project sooner and the few 
who were not, or became interested 
in other things, could consider re-
alistic options rather than spending 
more unproductive time in a Ph.D. 
program. This would a llow every-
one more time after GSBS to make 
contributions to society which is the 
ultimate goal. 
Another issue(s) is how ef-
fectively we prepare students to ad-
vance to candidacy in their first two 
years at GSBS. Could we do more 
in the tutorials to identify the needs 
of individual students and help 
them learn the skills we wish to test 
in the candidacy exam? Should ad-
visory committees meet more often 
in the second year to guide students 
more efficiently and effectively? 
Can we use advisory committee 
meetings to focus more explicitly on 
students' intellectual progress and 
critical thinking skills rather than 
emphasizing the preliminary results 
he/she has generated and suggest-
ing new experiments? Should we 
encou rage capable students with 
entrance deficiencies to begin their 
GSBS educations in the summer 
rather than the fal l term of their first 
year? Are there other creative 
things we can do? 
This is a major academic 
issue, and whatever we do should 
be faculty driven and invite student 
comment. I would like a ll of us to 
take a fresh look at this issue and I 
encourage Programs and individual 
facu lty to give it some serious 
thought; we would all benefit in the 
long run if we could reduce time to 
degree -- less might really be more 
at GSBS. 
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2006-2007 GRADUATES MASTER OF SCIENCE DEGREE 
Atkins, Krista! (Nacbum Dafny, Ph.D.) 
Behavioral and neurophysiological mechanisms underlying psychostimulants 
Curtis, Leigh (Roger Janz, Ph.D.) 
The role of syntax in 3B in retinal ribbon synapses 
Defant, J ennifer (Alex Vidaeff, M.D.) 
Preeclampsia and the trisomy 21 conceptus 
Greenberg, Brandon (Guillermina Lozano, Ph.D.) 
The role of mutant p53 in metastasis 
Grove, Megan (Eric Boerwinkle, Ph.D.) 
Gene environment interaction in the atherosclerosis risk and communities project (ARIC) 
Huynh, Ly (Thomas Goka, Ph.D.) 
Cysteine-switch control of the Ras/Raf/MEKIERK pathway in COS-7 and breast cancer cells 
Kline, Keith (David Eagleman, Ph.D.) 
Why is the perceived direction of motion sometimes opposite the actual direction 
Knisley, Alyssa (Jennifer Hoskovec, M.S.) 
Maternal serum screening: docs the frequency of abnormal results vary with ethnicity 
Lin, Pei-Chun (Xin Lin, Ph.D.) 
The molecular mechanism of G-protcin-coupled-rcccptor-mediatcd NF-kappaB activation 
Merritt, William (Menashe Bar-Eli, Ph.D.) 
Effects of targeting lL-8 on ovarian cancer 
l'iica, Alina (Peter Ruvolo, Ph.D.) 
Ceramidc induces cell death in chronic myeloid leukemia-derived K562 cells by a caspase-8-dependcnt 
apoptotic mechanism 
Patel, Purvi (Yong-Jian Geng, M.O./Ph.D.) 
The role of gclsolin and signal transducers and activators of transcription 3 (STAT3) in vascular smooth muscle 
cell iNOS expression 
Sa lo, Erin (Miguel Rodriguez-Bigas, M.D.) 
Survey of the cancers and genotype-phenotype correlations in the HNPCC patient population at 
UT M.D. Anderson Cancer Center 
Stanford, Amy (Sarah Noblin, M.S.) 
Expanded newborn screening in Texas: a survey and educational module addressing the knowledge of pediatric residents 
Stetson, Robert Chess (David Eagleman, Ph.D.) 
Plasticity and neural correlates of time perception 
Sullivan, Cathy (Terri IGng, Ph.D.) 
The impact of genes in glucose metabolism on rostral lesion location in patients with spina bifida meningomyelocele 
Tipps, Catherine (Jacqueline Hecht, Ph.D.) 
Trisomy 21, 18, and 13 in Texas: prevalence and mortality study 
Tseng, Jui-chuan (William Plunkett, Ph.D.) 
Cellular and molecular pharmacology of the S-phase checkpoint pathway: a mechanism for cell survival 
Uffort, Ocon (Julie Ellerhorst, .M.D.!Ph.D.) 
The regulation of the inducible nitric oxide synthase via the mitogen-activated protein kinase pathway through 
NF-kappaB activity 
Zhao, Ruiying (Mong-Hong Lee, Ph.D.) 
The COP9 signalosome subunit 6 (CSN6) is essential for early embryonic development in mice 
GRADUATion CELEBration 
Carter, J ennlter (Subrata Sen, l'h.U.) 
High-resolution microarray analyses of chromosome 20q amp Iicon in human colon cancer metastasis model systems 
Chang, Yao-Fu (Miles Wilkinson, Ph.D.) 
T-cell receptor nonsense-associated altered splicing 
Chen, Chih-llsin (Richard Behringer, Ph.D.) 
Comparative studies of Hox genes in mammalian limb and vertebral pattern formation 
Childre , J ennifer (Georg Halder, Ph.D.) 
Lethal giant discs, a novel C2 domain protein restricts notch activation during endocytosis 
Chunn, Janci (:\'lichacl Blackburn, Ph.D.) 
Adenosine induced pulmonary fibrosis and the contribution of the adenosine A2B receptor to the induction of osteopontin 
in a mouse model of pulmonary fibrosis 
Dembinski, J ennifer (Michael Andreeff, M.D./Ph.D.) 
Examination of the engraftment of exogenous mesenchymal stem cells in ovarian tumors and their potential use as delivery 
vehicles for therapeutic genes 
Den Hollander, Petra (Rakesh Kumar, Ph.D.) 
Nuclear functions of dynein light chain I in hormone action 
Edwards, Sharon (Richard Sinden, Ph.D.) 
Non 8 -D A structures and genetic instability associated with myotonic dystrophy type 2 (CCTG).(CAGG) repeats 
Fu, Xueyao (William Klein, Ph.D.) 
Mouse retinal development: role of cell adhesion and mechanism of gene regulation 
Hadjifrangiskou, Marla (Theresa Koehler, Ph.D.) 
Cis-acting elements and developmental regulators govern toxin gene expression in Bacillus Anthracis 
H awthorne, Valerie (Dihua Yu, M.DJ Ph.D.) 
Transcriptional upregulation of the p2 1cipl promoter by STAT3 and nuclear ERBB2 
Imam, Jaafer (Miles Wilkinson, Ph.D.) 
Regulation of R A splicing by nonsense mutations 
Johnson, Amber (Michelle Barton, Ph.D.) 
Hypoxia-induced transcriptional regulation through chromatin modifications and NC2 function 
Koch, icholas (Wayne ~ewhauser, Ph.D.) 
Monte Carlo and analytical dose calculations for ocular proton therapy 
Kry, tephen (Mohammad alehpoor, Ph.D.) 
The development and validation of a Monte Carlo model for calculating the out-of-field dose from radiotherapy treatments 
Leduc, Magalie (J ames Hixson, Ph.D.) 
Identification of genetic variation influencing apoE levels: follow-up of genome scans in GENOA 
Lin, Wenchu (Sharon Dent, Ph.D.) 
Requirement of GCN5 histone acetyl transferase in mouse neural tube closure and skeletal patterning 
Lyons, Jon (Pierre McCrea, Ph.D.) 
Analysis ofWNT/beta-catcnin signaling in kidney tubulogcncsis 
Mak, Solida (James llixson, Ph.D.) 
Expression study of atherosclerotic mouse aorta revealed significant disturbance of calcium signaling pathway 
Marks, Hilnry (Sara Peleg, Ph.D.) 
New insights into the role of the duodenal vitamin D receptor in calcium homeostasis 
Marsh, Rebecca (J ohn Hazle, Ph.D.) 
Measuring treatment response in irradiated murine tumors with diffusion-weighted magnetic resonance imaging 
Mashruwala, Mary Anne (Chinnaswamy Jagannath, Ph.D.) 
Regulation ofT cell function by compliment C5a in mice during mycobacterial infection 
Meng, Qingchang (Rakesh Kumar, Ph.D.) 
Regulation ofPoly-C-RNA binding protein I functions by PAKI signaling 
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COMMENCEMENT 2007 ADDRESS 
Robert D. Wells, Ph. D. 
Professor & Director 
Center for Genome Research 
Texas A&M University System Health Sciences Center 
Institute of Biosciences and Technology 
It's a wonderful day. Congratulations to all of you. I 
think it's fantastic. You've gotten your degree, and now 
you're off to other things. I'd like to say just a few words 
about what some of those other things might be. 
Keep in mind that change will occur in your lives. Wel-
come change. Embrace it. You will have three or four or 
five different careers in your lives. Don't be intimidated by 
that. In fact, to the contrary, as I say, embrace it and move 
forward. I think it's wonderful. 
What's going to happen in your lifetime, scientifically? 
Well, I don't know that, and I don't know that any of you 
know that; but l can tell you something about what's hap-
pened in my lifetime. I started graduate school in 1960, got 
my Ph.D. in '64 and as Dr. Stance! has said, I did a post-doc 
from '64 to '66. 
But what's happened in my lifetime? Let me just run 
down a list of some developments l think all of you know 
about, but you take for granted today. First of all, amino 
acid analyses of proteins. That came into ex istence when I 
was a graduate student, the Moore and Stein analyzers. 
Protein sequencing came into existence when I was a 
graduate student. The sequence of the first protein, insulin; 
the second, the coat protein of tobacco mosaic virus; the 
third, ribonuclease. We take protein sequences for granted 
today, but it was not always that way. 
Peptide synthesis came into existence in those days, and 
today we can chemica lly synthesize almost any molecule. 
That's phenomenal. When I started graduate school, that 
was out of the question. There were lots and lots of mol-
ecules like Vitamin B-12, etc., which were beyond the ca-
pability of chemical synthesis. 
Dr. Stance! mentioned the genetic code. That just fell 
out at our feet . It was the brilliance of Marshall Nirenberg 
and Gobind Khorana; because they developed the appro-
priate methodologies, the experimental results that solved 
this mystery, were obtained in about 18 months. And that 
code is the basis of virtually every grant proposal that goes 
through the National Institutes of Healrh today. 
We know, 1 would estimate, 90%, to 95% of all of the 
molecules in a cell. When l started graduate school, when I 
was in your shoes, there was no way we had that kind of 
knowledge. 
Cancer as a suitable ropic for serious research endeav-
ors has come into existence in my lifetime. The entire field 
of neurobiology has come from nothing. Restriction enzy-
mology and gene cloning didn't come into existence until 
the mid to the late 1970s. Eucaryotic genetics and molecu-
lar biology came into their own. When 1 was in your shoes, 
we could only study procaryotes; there were really only very 
"The Scientist Citizen" 
sparse studies that were going on in eucaryotic systems. 
The biotechnology industry flourished in the 1970s. 
When I was in your shoes, there were half a dozen or so 
companies that were selling what was basically reagents to 
the researcher. Today we have hundreds of biotech compa-
nies. That's also meant another change in the world, and 
that is that a number of scient ists have become wealthy. 
This also has been a major change because when I started 
my own laboratory, a number of scientists I could see around 
me were very comfortable, but they certainly weren' t 
wealthy. But that has now changed. 
The use of diverse cells and organisms has certainly cre-
ated a tremendous change in our science. The sequence of 
genomes, starting with the human genome but now scores 
of other genomes, is really very important and has given rise 
to the field of genomics. 
1 never dreamed, when I got my Ph.D. degree, that I 
would see another pandemic. l am old enough to remember 
polio and the polio issues when I was a teenager. But today 
we have AIDS, we have obesity, and we have diabetes. And 
so there are many challenges that are out there in front of 
you. 
Xerox machines have altered science. It's true. When 
I was a graduate student, there was no such thing as a Xerox 
machine. And 1 invited - that's a nice word to use - I in-
vited my wife, Dotty, to come tO the library with me on 
several evenings and to copy down methodologies that I 
needed for the next day's experiments because there was no 
way to duplicate it. But in fact we take this for granted 
today. And of course the Internet searches for scientific 
papers have really made the search of the scientific li tera-
ture much, much more easy. 
So what's going to happen in your lifetime? Well, I 
don't have a crysta l ball, and I can't tell you the specifics. 
But in general, it's going to be the investigation of the spa-
tial and the temporal interrelationships between these mol-
ecules that we know exist in a cell. In other words, how do 
you put it all together, and what is the wiring diagram? 
Let me tell you a small side story, and that is that I gave 
an endowed lecture at the M. 0. Anderson Cancer Center 
in Smithville within the past year. A young faculty mem-
ber had some background on me such as Dr. Stance! has just 
reviewed. He said, "Oh, Or. Wells, you've done such great 
things in your life. Your generation has solved virtually all 
of the important problems in biology." I told him at that 
point that I didn't believe that for a second. In fact, quite to 
the contrary, I think it is your generation that has the op-
portunity to reach out and to make much more profound 
discoveries than, in fact, in the previous generation. 
Why do people do science? Why are you sitting here? 
Why have you worked so hard to get your Ph.D. degree? I 
think there are fundamentally three reasons why people go 
into science, or some mixture of these reasons. Number 
one is altruistic, namely, to contribute knowledge, and that's 
very important. The second reason is money. You know 
that there is a chance that you will have a comfortable 
lifestyle. I think that's very important, and I think we ought 
to talk about that sort of thing. But the third reason is curi-
osity. There are some of you who could not do anything 
else. You were driven to learn a science. So I think there 
are basically those three reasons why people get into sci-
ence. 
Now let me say a few words more to add to Dr. Dent's 
remarks regarding responsibilities. As a scientist, you have 
a responsibili ty to be a good citizen. What does that mean ? 
Well, you must define that, and it will change in your life-
time. But, number one, I would say, this means you must 
vote . Very simple. Vote. Stand up for the individuals chat 
you think are going to do the right thing for society and also 
for medica l research and for science. 
Second, speak out on the issues. Do not keep quiet. 
Look at what's going on with evolution today in this coun-
try. Look at what's going on with a wide range of other 
issues. And legislators, members of Congress, do not know 
what's going on in science. They rely on you. You've got to 
tell them. So get involved with your congressmen, either in 
your home district or in Washington. Next, advise the gen-
eral population. Get involved with c ivic groups. Get in-
volved in church groups. Get involved in any sort of orga-
nization where you have the privilege of talking with people 
and expressing your views concerning the funding for medi-
cal research. 
Yes, we were successful in getting the budget for the 
NIH doubled from 1999 to 2004, but due to a very hard 
landing, we find ourselves in a situation where it is much 
harder for scientists to get funded today. And so we've got 
to interact with and influence Congress to inform them of 
the needs of the medical research community. They don't 
know this a priori. In fact, only a few percent of everybody 
in the United States, less than ten percent of all people in 
the United States, know what federal agency funds medical 
research. Let me repeat that. It's less than ten percent of 
the general public who can tell you that it is NIH, National 
Institutes of Health, that funds medical research. 
A lternatively, Research A merica, an organization in 
Washington, has taken another poll to ask the question, 
"How important do you think medical and health research 
is to the U.S. economy:" 94% said important, 4% not im-
portant, and 2% said they didn't know. Hence, the Ameri-
can public does support medical research, but they don't 
know very much about it; so you've got to get involved. 
In addition, jo in your scientific societies. If you're a micro-
biologist, that's ASM, A merican Society for Microbiology. 
If you're a biochemist, that's ASBMB, American Society 
for Biochemistry and Molecular Biology; cell biology is the 
American Society for Cell Biology. These are the organiza-
tion that work together as a group of scientists to, in fact, 
try to effect change in Washington. And so my message 
regarding science and your citizenship is, get involved. 
Your road in the future may not always be easy. You 
know that. And you may need to persevere. Perseverance 
has certainly been a hallmark in my life. In my research 
programs, we have worked for 38 years to discover new types 
of non-B-DN A structures, such as cruciforms, slipped struc-
tures, bent DNA, etc.; however, it has taken all of this time 
to understand the biological functions of these structures. 
But it's only about two years ago that, in fact, we learned 
that these structures arc at break points for gross deletions, 
rearrangements, etc., that cause some 70 human diseases. 
So, I have worked for roughly 38 years to lay the background 
but it has only been within the past couple years that we 
have really d iscovered the medical implications of these dis· 
coveries. 
Therefore, you need to persevere in your activities. 
Thinking of perseverance always reminds me of a wonder-
ful, humorous story about the penguin and the bar. T he 
penguin went into a bar one day and asked the bartender, 
"Do you have any grapes?" T he bartender says, "No." T he 
penguin walks out. The second day, the penguin walks back 
into the bar and asks the question, "Got any grapes?" The 
bartender says, "No. And I hope you'll get out of here." 
The penguin walked out. The third day, the penguin walks 
back into the bar, asks the bartender, "Got any grapes?" The 
bartender says, "No, and get out of here because if you don't, 
if you come back again, I'm going to nail your webbed feet 
to the floor." Fourth day. What happens? The penguin 
walks back into the bar and says to the bartender, "You got 
any nails?" The bartender says, "No." The penguin says, 
"Got any grapes?" 
So persevere in your endeavors. Have great fun. And 
congratulations. 
John P. McGovern Outstanding Teaching Award 
The annual John P. 
McGovern Outstanding Teacher 
award winners are nominated and 
elected by the student body based 
on a number of criteria which in -
clude: excellent and enthusiastic 
teaching, the ability to stimulate and 
encourage independent thinking, 
responsiveness to student questions, 
and finally, a commitment to, and 
passion for, student academic and professional develop-
ment. The winner of this year's award, Dr. Kevin 
Morano, demonstrates all of these qualities. 
As a researcher, Dr. Morano is well known in 
his field of Microbiology and Molecular Genetics for his 
excellent work, and has won a number of research awards 
to commemorate this. 
Dr. Morano is an excellent scientist, dedicated 
to adding quality work into the body of knowledge of h is 
field and he sets an example that demonstrates how ba-
sic research can be useful for cll!ing diseases and saving 
lives. He supports the student body in everything that 
he does- from mentoring students to teaching classes to 
actively participating in the GSBS. He is devoted to 
the students ana works hard to help us develop as inde-
pendent thinkers and as scient ists. Dr. Morano motivates 
those around him to achieve excellence by his act ions 
and his words • he embodies the concept of an outstand-
ing teacher. 
-Pat Gibney, Graduate Student Associati<m president, 2006-2007 
7 


10 
COMMENCEMENT GREETINGS 
from the GSBS Faculty President 
Sharon Roth Dent, Ph.D. 
GSBS Faculty President, 2006-2007 
I am so very happy and honored to welcome you all here today. I con-
gratulate each of you, along with your families, loved ones, and mentors who have 
stood behind you on this quest, on the completion of your degree. 
I have been a faculty member here since 1993, so I have heard many excellent and inspiring speeches from my esteemed 
colleagues on graduation day. l think one of my favorites was by Or. Kripke, when she was President of the graduate 
faculty. She began by assuring everyone that she would not take too long, because she knew that most people are roo 
excited on occasions like this to remember what the speakers say, but they almost always remember how Long it took them 
to say it. I too will strive to be concise. 
When I graduated with my Ph.D. back in mid 1980s, my degree was actually printed on a sheepskin, so it took 
awhile to prepare. As we walked across the graduation stage, we did not get a diploma. Instead we got a rolled up p1ece 
of paper, which likely told us when and where to go pick up our actual diplomas. 
I, like you, was feeling very proud and I was so looking forward to moving on to the next stage of life. So I did not 
mind that I had to wait for the diploma to be ready. No more qualifying exams; no more meetings with my committee; I 
was done!! When I actually got my degree a few weeks later and read through it, I was pleased to sec that they had spelled 
my name right and thrilled that it said I had a PhD. However, I w-as a little taken aback by the last line, which read " ... all 
the rights, duties, and privileges appertaining to that degree." I was ready for new rights, and I was already expecting some 
new privileges. In fact, I had already begun a post doc and I was enjoying very much no longer having to struggle by on a 
student's salary. But what was this stuff about duties?? 1 guess that was the first time that I realized that a higher degree is 
not just a stepping stone; it is a lifelong title that reflects expectations that others now have of you. 
So I ask you, are you ready for your duties as a scientist? What do you think these duties are? You arc probably 
thinking, well that depends on what kind of job I get, on what my boss wants me to do, on what my spouse wants me to do. 
But I am talking about fundamenral duties that come with higher learning. Although there are numero us such duties we 
could discu today, I want to focus on just three. 
The fi rst and foremost duty, in my mind, of a scientist is to uphold the highe t standards of excellence and integrity-- in 
your science, in your teaching, and in your life. 
Aristotle said, 
"Excellence is an art won by training and habituation. We do not act righrly because we have virtue or excel-
lence, hut we rather have those because we have acted rightly. We are what we repeatedly do. Excellence, then , 
is not an act hut a habit." 
It is our duty to make excellence our habit. 
The second duty we have is co make a difference, to use our learning to push the envelop whenever po ible. This 
duty will require some courage, a lot of dedication, and it may involve some risk. But to paraphra e David Lloyd George 
(a WW I era British statesman), "Don't be afraid to take a big leap; you can't cross a chasm in two small jumps." 
However, that is not to say that small steps arc not important. Sometimes the biggest advances come from a series of 
painstaking studies. just make sure that even your small steps are strong ones that will move you in a forward direction. 
Never stop learning and always strive for significance. 
Our third duty, I think, is to 'pay it forward'. All of us got to this point in our live and our careers with support 
and guidance from family, mentors, teachers, even committee members. You may not ever be able to pay everyone back 
for that support, but you can pass it on to future generations of young scientists, or to anyone who i eager to learn. I urge 
you to give freely of yourself. You'll be surprised how often such giving enriches your own life. 
I' ll end with a quote from Tom Brokaw, which must have been i ued at a commencement exercise much like this 
one. He said, 
"You are educated. Your certification is in )'Our degree . You may think of it as rhe ticket 10 the good life. Let me 
ask you to think of an alternative. Think of it as your ticker to change the world." 
On behalf of all the faculty: Congratulations, good luck, and stay in couch! 
Faculty honors 
Michelle Barton, Ph.D. noted that the 
Genes and Development program 
received a $250,000 gift fi·om the 
Wil liam Randolph Hearst Foundation 
through the efforts ofUT M.D. 
Anderson development office and will 
provide for two graduate student 
stipends each year and two faculty 
"seed" grants for innovative research 
involving graduate student trainees. 
Robert Chamberlain, Ph.D. was 
awarded the Margaret Hay Edwards 
Acb.ievement meda l presented by the 
American Association of Cancer 
Education. 
Robin Fuchs-Young, Ph.D. has 
received a five-year $750,000 grant 
fi·om the Howard Hughes Medical 
Institute for a new education program 
to "open mi11ds to health, science and 
careers." 
J acqueline Hecht, found ing director 
of the GSBS Generic Counseling 
program, received the 2007 Barbara 
Bowman Djstinguished Texas 
Geneticist Award from the Texas 
Genetics Society. 
Mien-Chie H ung, Ph.D., Robert 
Chamberla in, Ph.D., E mil Freireich, 
M.D., Michael Ahearn, Ph.D. and 
Stephen Tomasovic, Ph.D. were 
recommended for an award of The 
University ofTexas System title of 
Distinguished Teaching Professor. 
E dward Jackson, Ph.D. ( 1990/ 
Naryana) is Pl for the first Medical 
Physics NiH T-32 Training grant 
totalling $1.9 Mover five years. 
E ugenie KJeinerman, M.D. was 
honored with the 2006 Duke Univer-
sity Distinguished Medical Alumni 
Award. 
Cheng Chi Lee, Ph.D. wins NlH 
Director's Pioneer Award, $2.5M over 
five years to further his research. 
Steven Norris, Ph.D. was a recipient 
ofthe inaugural UT Chancellor's 
Entrepreneurship and r nnovation 
Award for his research in the develop-
ment of a Lyme Disease test. Two 
graduate students involved in the 
research were J ing-Ren Zhang and 
Matthew Lawrenz. Jing is now an 
assistant professor at Albany Merucal 
College, and Matt is a postdoctoral 
fellow at Washington University 
School ofMedicine in St. Louis. 
Hope NortbJ·up, M.D. opens the 
region's first clinic at Memorial 
Hermann l-lospital dedicated to the 
diagnosis and treatment of Tuberous 
Sclerosis Complex (TSC). 
Stanley Schultz, M.D. Teceived the 
Prince Mahidol Award for Medicine 
in Taiwan for his contributions to the 
rationale that led to the development 
of oral rehydration therapy. 
J ohn Spudich, Ph.D. was elected a 
Pellow of the American Academy of 
Arts and Sciences. 
H einrich Taegtmeyer , M.D.,D.of Ph. 
was elected president of the Interna-
tional Society for Heart and Vascular 
Metabolism. 
Xinping Zhao, Ph.D. received the 
24th Biennial Cornea Research 
Conference Conm1itteeAward. 
UT M. D. Anderson F acnlty Schola r 
Awards: Mark Bedford, Ph.D., Peng 
Huang, M.D., Ph.D.,ALtil Sood, 
M.D.; Faculty Achievement Awards: 
Cheryl Walker, Ph.D., John 
DiGiova1tni, Ph.D., Pierre McCrea. 
Ph.D. 
UT H ealth Science Cente1· 
President's Scholar Award for 
ExceUence in R esear ch : Ponnada 
Narayana, Ph.D., Ferid Murad, M.D., 
Ph.D.; President's Scholar Award for 
ExceiJence in Teaching: Henry 
Strobel. Ph.D. Young Investigators 
noted: Kevin Morano, Ph.D .. Ambro 
van Hoof, Ph.D., Blanca Restrepo, 
Ph.D., Peter Ruvolo. 
D eparting Faculty: 
Bruce Kone, M.D., Ph.D. to become 
Dean of the University ofFlorida 
College ofMedicine. 
Kenneth Wu, M.D., Ph.D. to begin a 
new position as president and distin-
guished investigator of the National 
Health Research Institutes in Taiwan. 
Stanley Reiser , Ph.D. an internation-
ally known scholar and pioneer in 
ethics, and longtime (1983-2007) co-
creator of the GSBS course The 
Ethical Dimensions in the Biomedical 
Sciences starts a new position at The 
George Washington University. 
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Members Reappointed with 
Highest Commendation 
Sharon Dent 
Ruth Heidelberger 
Diane Hickson, Bick 
Edward 1 ackson 
Ralf Krahe 
Richard Kulmacz 
Guillermina Lozano 
Pierre McCrea 
1 agannadha Sastry 
Heinrich T aegtmeyer 
Dihua Yu 
Members Reappointed 
With Commendation 
Phillip Carpenter 
Stephen Daiger 
Carmen Dessauer 
David Followill 
1 acqueline Hecht 
Peng Huang 
Yuan 1i 
1ian Kuang 
William Margolin 
David McConkey 
Emeritus 
Member Appointed 
Harry Sperling 
Retiring in August (except for 
special projects) faculty member, 
and long a valuable resource for 
edu cation, Margaret Kripke, 
Ph.D., Executive Vice President 
and Chief Academic Officer at 
M.D. Anderson Cancer Center 
is presented with an aerial view 
of the Texas Medical Center and 
a silver bracelet inscribed with 
her years of service to GSBS: 
1983-2007 
NEW 
Regular Members 
Christian R. Abee 
Doctor, R. Lee Clark Professor and Chair 
Veterinary Sciences 
M. D. Anderson Cancer Center 
D.V.M., Texas A & M University, 1971 
Research interests: nonhuman primate dis-
ease models; primate reproductive biology; 
assisted reproductive technologies 
Jonas S. Almeida 
Professor 
Biostatistics and Applied Mathematics 
M. D. Anderson Cancer Center 
Ph .D., University of Lisbon, 1995 
Research interests: systems biology; 
biomarker identification; drug/target dis-
covery; statistical mechanics 
Banu Arun 
Associate Professor 
Breast Medical Oncology/ 
Clinical Cancer Prevention 
M. D. Anderson Cancer Center 
M.D., University of Istanbul, l990 
Research interests: breast cancer risk assess-
ment; identification of risk markers, surro-
gate biomarkers and novel preventive and 
treatment agents 
E. Neely Atkinson 
Professor 
Biostatistics and Applied Mathematics 
M. D. Anderson Cancer Center 
Ph.D., Rice University, 1981 
Research interests: optical methods for early 
detection of cancer; design and analysis of 
clinical trials; modeling of dose-response 
curves and surfaces 
Gabor Bahizsi 
Assistant Professor 
Molecular Therapeutics 
M. D. Anderson Cancer Center 
Ph.D., University of Missouri - Sr. Louis and 
Rolla, 2001 
Research interests: mathematical/computa-
tional modeling and experimental charac-
terization of biomolecular interaction net-
works 
Richard G. Brennan 
Professor and Robert A. Welch Distin-
<>uished University Chair in Chemistry 
Biochemistry and Molecular Biology 
M. D. Anderson Cancer Center 
Ph.D., University of Wisconsin - Madison, 
1984 
Research interests: multidrug resis tance, 
protein-nucleic interaction, regulation of 
gene expression; oxidative stress responses; 
protein-ligand interaction, toxin-antitoxin 
structure and function; macromolecular 
crystallography 
Claudio N. Cavasotto 
Assistant Professor 
UT-H School of Health Information 
Sciences 
Ph.D., University of Buenos Aires, L999 
Research interests: computat ional chemis-
try; compU[ational biology; ligand-based and 
structure-based drug discovery; protein-
ligand and protein-protein interaction; 
force-field development; cheminfonnatics 
Shine Chang 
Associate Professor, Epidemiology 
M. D. Anderson Cancer Center 
Ph.D., University of North Carolina at 
Chapel Hill, 1995 
Research interests: cancer prevention and 
control; biobehavioral determinants of obe-
sity; epidemiology; health science research 
training and evaluation; career develop-
ment programming and professional educa-
tion 
Laurence J. N. Cooper: 
Associate Professor, Pediatrics 
M. D. Anderson Cancer Center 
Ph.D., Case Western Reserve University, 
1993 
M.D., Case Western Reserve University, 
1994 
Research interests: immunotherapy; T-cell 
therapy; gene therapy; hematopoietic stem-
cell transplantation; bone marrow trans-
plantation; development of immunological 
approaches to treat pathogens and malig-
nancies; pediatrics 
Brian R. Davis 
Associate Professor 
Ce11Lre fur SLeut Cell Re:;t::ardt 
UT-H Institute of Molecular Medicine 
Ph.D., California Institute of Technology, 
1980 
Research interests: gene editing of stem 
cells; stem cell biology; gene therapy; he-
matopoietic stem cells; somatic reversion; 
molecular genetics 
John F. de Groot 
Assistant Professor, Neuro-Oncology 
M. D. Anderson Cancer Center 
M.D., UT Medical Branch at Galveston, 
1998 
Research interests: role of glutamate trans-
porters and receptors in the regulation of 
growth and progression of human glial neo-
plasms; regulatory loops in human gliomas 
and their effects on cellular proliferation 
and migration 
Mauro Ferrari 
Professor and Director, NanoMedicine 
UT-H Institute of Molecular Medicine 
Ph.D., Universiry of California, Berkeley, 
1989 
Research interests: biomedical 
nanotechnology; translational science; 
medical therapeutics in drug delivery ap-
plication in oncology, cardiovascular dis-
ease and diabetes; biosensors and 
biosepar.ation technology; multiscale dis-
crete/continuum mechanics and 
biomechanics 
Michael T. Gillin 
Professor/Deputy Chair and Chief 
Radiation Physics/Clinical Services 
M. D. Anderson Cancer Center 
Ph.D., University of California at 
Davis, 1970 
Research interests: clinical application of 
protons; clinical trials; infonnation manage-
ment; calibration of radiation beams 
Vidya Gopalakrishnan 
Assistant Professor, Pediatrics 
M.D. Anderson Cancer Center 
Ph.D., University of Pittsburgh School of 
Medicine, 1995 
Research interests: pediatric brain tumors; 
identification of novel therapeutic targets; 
regulation of transcription factors in brain 
tumors and normal brain development 
Barrett R. Harvey 
Assistant Professor 
UT-Houston 
lnstitU[e of Molecular Medicine 
Ph.D., Universiry of Texas at Austin, 2003 
Research interests: applied biologics; recom-
binant antibodies; directed evolution; high 
throughput selections 
H amed Jafar-Nejad 
Assistant Professor 
UT-H Institute of Molecular Medicine 
M.D., Tehran University of Medical 
Sciences, 1994 
Research interests: cell biological regulation 
of signaling pathways; neuronal precursor 
specification and differentiation; intracel-
lular trafficking; asymmetric division; sugar 
modification of signaling proteins 
Valen E. Johnson 
Professor 
Biostatistics and Applied Mathematics 
M. D. Anderson Cancer Center 
Ph.D .• The University of Chicago, 1989 
Research interests: Bayesian analysis with 
a focus on Bayesian model diagnostics and 
testing; ordinal and categorical analysis; 
model selection and Bayesian model aver-
aging; statistical image analysis 
Tetsu Kamitani 
Associate Professor, Cardiology 
M. D. Anderson Cancer Center 
M.D., Toyama Medical and Pharmaceuti-
cal University, 1985 
Ph.D., Toyama Medical and Pharmaceuti-
cal Universiry, 1990 
Research interests: post-translational modi-
fication; regulation by ubiquitination; con-
jugation with ubiquitin-like prote in; 
SUMO; NEDD8; proteolysis by 
proteasome; function of NUBl; 
ubiquitination by Ro52; ubiquitination by 
TRIMS 
Aarif Khakoo 
Assistant Professor, Cardiology 
M. D. Anderson Cancer Center 
M.D., Columbia Universi ty, College of 
Physicians and Surgeons, 1999 
Research interests: cardiomyopathy; chemo-
therapy; receptor tyrosine kinases; platelet 
derived growth factor; cell signaling; car-
diac development; cardiac physiology 
Jeri Kim 
Associate Professor 
Genitourinary Medical Oncology 
M. D. Anderson Cancer Center 
M.D .. University of Southern California, 
School of Medicine, 1993 
Research interests: prostate cancer preven-
tion and treatment 
Mikhail G. Kolonin 
Assistant Professor 
Centre for Stem Cell Research 
UT-H Institute of Molecular Medicine 
Ph.D., Wayne State University, 2000 
Research interests: mesenchymal stem cells; 
mechanisms of adult stem cell mobilization/ 
rnigration/engrafnnent; role of mesenchy-
mal stem cells in cancer vasculogenesis; role 
of adipose tissue/adipose stern cells in can-
cer progression 
Frederick F. Lang 
Professor/Director 
Neurosurgery/Clinical Reseatch 
M. D. Anderson Cancer Center 
M.D., Yale Universiry School of Medicine, 
1988 
Research interests: role of end terminal 
phosphorylation in p53-mediated apoptosis; 
human mesenchymal stern cells as delivery 
vehicles for gliomas; cancer stem cells in 
brain tumor formation; animal models of 
brain tumors 
Dina Che1ouche Lev 
Assistant Professor 
Cancer Biology 
M.D. Anderson Cancer Center 
M.D., Sackler School of Medicine, 
Tel Aviv University, 1993 
Research interests: soft tissue sarcoma; 
chemoresistance; angiogenesis; 
lymphangiogenesis; metastasis; pre-clinical 
therapeutic models; tumor microenviron-
ment; gene therapy; p53 rumor suppressor 
gene function; siRNA; signal transduction 
pathways; tissue microarrays; high through-
put assays 
Hui-Kuan Lin 
Assistant Professor 
Molecular and Cellular Oncology 
M. D. Anderson Cancer Center 
Ph.D., University of Rochester, 2002 
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Research interests: tumor suppressor gene/ 
oncogene in cancer development; protein 
phosphorylation 
Nami McCarty 
Assistant Professor 
Centre for Stem Cell Research 
UT -H Institute of Molecular Medicine 
Ph.D .. Purdue University, 2000 
Research interests: human and mouse stem 
cell differentiation; gene regulation; RNAi; 
hematOpoietic stem cell development; T/B 
cell development :md differentiation; au-
wimmune diseases 
Sattva S. N eelapu 
Assistant Professor 
Lymphoma and Myeloma 
M. D. Anderson Cancer Center 
M.D., Jawaharial Institute of Post..(Jradu-
ate Medical Education and Research, 1991 
Research interests: tumor immunology; can-
cer vaccines; novel tumor antigen discov-
ery; adoptive T -cell therapy; immunologi-
cal monitoring; lymphoma 
Andrew C. Papanicolaou 
Professor and Director 
Developmental Pediatrics/ 
Neurosurgery & Neurology 
Cente r for Clinica l Neurosciences, 
Children's Learning Institute, 
UT-11 Medical School; Diretor 
Ph.D., Southe rn Illinois University at 
Carbondale, 1977 
Research interests: specification of brain 
mechanisms of linguistic affective and cog-
nitive functions; brain activity signs of de-
ve lopmental disorders; localization of 
sources of epileptiform activity 
Laszlo G. Radvanyi 
Associate Professor 
Melanoma Medical Oncology 
M. D. Anderson Cancer Center 
Ph.D., University of Toronto, 1996 
Research interests: rumor immunology; 
melanoma; breast cancer; immunotherapy; 
adoptive T-cell therapy; tumor vaccines; 
antigen discovery 
Xiujiang John Rong 
Assistant Professor, Imaging Physics 
M. D. Anderson Cancer Center 
Ph.D., University of Missouri • Columbia, 
1996 
Research imerests: radiation dosimetry; 
medical image quality evaluation and mea· 
surement; computed tomography; digital x-
ray imaging 
Dos D. Sarbassov 
Assistanr Professor 
Molecular and Cellular Oncology 
M. D. Anderson Cancer Center 
Ph.D., University of Arkansas for Medical 
Sciences, 1997 
Research interests: cell signaling; regulation 
of cell growth, proliferation, survival, and 
migrat ion; rapamycin and the mTOR 
(mammalian Target Of Rapamycin) path-
way; kinases and phosphatases; anti-cancer 
drug development 
Robert J. Schwartz 
Professor and Director 
Texas A&M Un iversity Institute of Bio· 
sciences and Technology 
Director, Center for Molecular Develop-
ment and Disease 
Ph.D., University of Pennsylvania, 1972 
Research interests: gene regulation; mecha-
nisms in transcription; embryonic develop· 
ment; formation of the cardiovascular sys· 
tem; myogenesis; gene networks 
Padmanee Sharma 
Assistant Professor 
Genitourinary Medical Oncology/ 
Immunology 
M. D. Anderson Cancer Cenrer 
M.D., Ph.D., Pennsylvania State Univer· 
sity, College of Medicine, 1998 
Research interests: immunological studies 
re lated to genitourinary malignancies; de-
velopment of future immunotherapeutic 
strategies; role of effector and regulatory T-
cells in anti-tumor immune responses; ru· 
mor antigen expression and immune re-
sponses against tumor antigens; cytokine 
profile in tumor microenvironment 
Paul J. Simmons 
Professor and Director 
Centre for Srem Cell Research 
UT-H Institute of Molecular Medicine 
Ph.D., University of Manchester, 1985 
Research interests: stem cell biology; mes-
enchymal stem cells; hematopoiesis; cell 
adhesion molecules; stem cell mobilization; 
skeletal biology; monoclonal antibodies 
Robert Y. L. Tsai 
Assistant Professor 
Center for Cancer and Stem Cell Biology 
Institute of Biosciences and Technology 
Texas A&M Health Science Center 
M.D., National Taiwan University, 1988 
Ph.D., Johns llopkins University, 1996 
Research interests: stem cells; neural stem 
cells; neurodevelopment; neucleostemin; 
aging; cancer; regeneration 
YiXu 
Assistant Professor 
Center for Extracellular Matrix Biology 
Texas A&M Univea:osity, Institute of 
Biosciences and Technology 
Ph.D., UT-H GSBS, 1998 
Research interests: bacteria and host inter-
actions; bacterial pathogenesis; host cellu-
lar machinery; innate immune response; 
bacterial surface proteins 
Qing Yi 
Associate Professor 
Lymphoma and Myeloma 
M. D. Anderson Cancer Center 
M.D., J iangxi Medical College, 1983 
Ph.D., Karolinska Institute, 1993 
Research interests: tumor immunology; 
immunotherapy; dendritic cell vaccination; 
antibody therapy; myeloma mouse models; 
multiple myeloma 
Dekai Zhang 
Assistant Professor 
Center for Extracellular Matrix Biology 
Texas A&M University Institute of 
Biosciences and Technology 
M.D., Harbin Medical College, 1993 
Ph.D., University of Hong Kong, 1998 
Research interests: innate immunity; patho-
gen-host interactions; inflammation and 
infecrious diseases 
Dapeng Zhou 
Assistant. Professor 
Melanoma Medical Oncology/ 
Immunology 
M. D. Anderson Cancer Center 
M.D., Shanghai First Medical College, 1994 
Ph.D., University of Zurich, 2000 
Research interests: T cell biology; antigen 
presentation; immunotherapy; therapeutic 
vaccines 
NE\\' 
Associate Memlwrs 
Ana M. Aparicio 
Assistant Professor 
Genitourinary Medical Oncology 
M. D. Anderson Cancer Center 
M.D., Universidad Autonoma de Madrid, 
1995 
Research interests: epigenerics; DNA me-
thylation; DNA methylat ion inhibitors; 
histone deacetylase inhibitors; prostate can-
cer; genitOurinary malignancies 
Krishnakumar Balasubramanian 
Assistant Professor, Cancer Biology 
M. D. Anderson Cancer Center 
Ph.D., Institute of Microbial Technology, 
1997 
Research interests: mechanisms in apoptosis 
and phagocytosis; resistance to drugs and 
death ligands; metastasis and acquisition of 
metastatic potential 
Tina Marie Briere 
Instructor, Radiation Physics 
M. D. Anderson Cancer Center 
Ph.D., State University of New York at 
Albany, 1995 
Research interests: ga rrointestinal tumor 
motion; in vivo patient dosimetry 
Martin Bues 
Instructor 
Radiation Physics 
M. D. Anderson Cancer Center 
Ph.D., Harvard University, 1996 
Research interests: proton therapy; inten-
sity modulated radiation therapy; gated ra-
diation therapy; prostate brachytherapy 
Suhendan Ekmekcioglu 
Assistant Professor 
Experimental Therapeutics 
M. D. Anderson Cancer Center 
Ph.D., University of Istanbul, 1993 
Research interests: signaling pathways in 
melanoma; regulation of survival factors in 
melanoma; molecular prognostic markers 
Suzanne L. Craig 
Associate Professor 
Veterinary Medicine & Surgery 
M. D. Anderson Cancer Center 
D.V.M., Tuskegee University School of 
Veterinary Medicine, 1989 
Research interests: animal models; experi-
mental design; cancer biology; comparative 
medicine; animal imaging; immunology 
William D. Erwin 
Senior Medical Physicist, Imaging Physics 
M. D. Anderson Cancer Center 
M.S., DePaul University, 1991 
Research interests: quantitative gamma 
camera imaging; septal penetration; scatter 
and attenuation correc tion; iterative 
SPECT reconstruction; hybrid SPECT/CT 
imaging; yttrium-90 bremsstrahlung imag-
ing; internal radionuclide dosimetry; radio-
nuclide therapy treatment planning 
Carl S. Hacker 
Associate Professor 
Management, Policy and 
Community Health 
UT -H School of Public Health 
Ph.D., Rice University, 1968 
J.D., University of Houston Law Center, 
1987 
Research interests: urban ecology; 
vector biology; public health law and policy 
Andrea E. Harbison 
C linical Instructor 
Pediatrics 
UT-H Medical School 
M.S., University of Cincinnati, 2005 
Research interests: genetic counseling; 
prenatal 
Jennifer M. H oskovec 
Clinical Instructor 
Obstetrics, Gynecology and 
Reproductive Sciences 
UT-H Medical School 
M.S., UT-H GSBS, 2003 
Research interests: genetic counseling; 
prenatal 
Aaron K. Jones 
Instructor, Imaging Physics 
M. D. Anderson Cancer Center 
Ph.D., University of Florida, 2006 
Research imeresrs: optimization of diagnos-
tic imaging protocols (especially pediatrics) 
with regards to absorbed dose and image 
quality; phantom design and construction; 
radiation dosimeter design, construction 
and testing; image quality assessment; im-
age processing; computed tomography, 
computed radiography, digital radiography 
Malgorzata Kloc 
Associate Professor 
Molecular Genetics 
M.D. Anderson Cancer Center 
Ph.D., Warsaw University, 1978 
Research interests: development; axial pat-
terning; RNA localization 
Anita Mahajan 
Associate Professor 
Radiation Oncology 
M. D. Anderson Cancer Center 
M.D., McGill University, 1992 
Research interests: stereotactic radiosurgery; 
brain tumors; pediatric radiation oncology 
Mark J. McArthur 
Associate Professor 
Veterinary Sciences 
M. D. Anderson Cancer Center 
D.V.M., Texas A & M University, 1979 
Research interests: pathology of genetically 
engineered mi.ce; p53; COX-2 in carcino-
genesis; mouse models of pancreatic and 
urinary bladder cancer 
Ramaswamy Sadagopan 
Senior Medical Physicist 
Radiation Physics 
M.D. Anderson Cancer Center 
M.S., UT-H GSBS, 1989 
Research interests: medical physics 
Miguel A. Rodriguez-Bigas 
Professor 
Surgical Oncology 
M. D. Anderson Cancer Center 
M.D., University of Puerto Rico, 
School of Medicine 
Research interests: surgical oncology; 
colorectal cancer 
David L. Schwartz 
Assistant Professor 
Radiation Oncology 
M. D. Anderson Cancer Center 
M.D., University of California 
Los Angeles School of Medicine 
Research interests: multi-modality molecu-
lar genetic imaging of small animal preclini-
cal models; head and neck; radiation on-
cology; medical imaging; radiobiology 
Claire N. Singletary 
Assistant Professor 
Pediatrics 
UT-Houston Medical School 
Director, Genetic Counseling 
S.M.S. Program 
M.S., Northwestern University, 1998 
Research interesrs: genetic counseling 
Donna M. Stevens 
Senior Medical Physicist 
Imaging Physics 
M. D. Anderson Cancer Center 
M.S., University of Colorado Health 
Sciences Center, I993 
Research interests: medical physics; diag-
nostic radiological physics 
Sastry Vedam 
Assistant Professor 
Radiation Physics 
M. D. Anderson Cancer Center 
Ph.D., Virginia Commonwealth University, 
2003 
Research inreresrs: respiratory motion man-
agement in radiotherapy; image guided ra-
d iotherapy; 4D CT; 4D cone beam CT; 
PET; 4D treatment planning and delivery 
Alex C. Vidaeff 
Associate Professor 
Obstetrics, Gynecology & Reproductive 
Sciences 
UT-H Medical School 
M.D., University of Bucharest, 1977 
Research interests: hormonal regulation of 
gene expression; genomic and non-genomic 
effects of corticosteroids; prematurity 
prevention 
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Aaron Blanchard Research Award in Medical Physics 
Named in memory of Aaron M. Blanchard, a GSBS sLudcnt in rhe Medical Physics Program who suc-
cumbed to brain cancer in 1998, lhb $300 cash award recognizes a Medical Physics graduate (M.D. or 
Ph.D.) for completion of an outstanding thesis or dissertation judged to make a significant conrribution to 
cancer therapy or diagnosis. This will become a formal award endowment in 2007-2008. Award recipient 
for 2006-2007 is: 
Student Advisor 
Jennifer O'Daniel Dr. Lei Dong 
American Legion Auxiliary Scholarship Awards 
Since 197 .1 the Amencan Legion Auxiliary has 
provided scholarships for GSBS sLUdents involved 
in cancer research. The money for this fu nding is 
raised through a wide range of Auxiliary activi-
ties. To date the Auxi liary has rai ed over 
$1,100,000 to prescnL over 80 renewable schol-
arships of $5,000 each. The 2006-2007 recipi-
ents are: 
Student 
Kendra Carmon 
Jennifer Caner 
Sarah Dunlap 
Omar Duramad 
Shannon Kidd 
Advisor 
Dr. David Loose 
Dr. Subrata Sen 
Dr. Wei Zhang 
Dr. F. Xiao-Feng Qin 
Dr. Paul Simmons 
Student 
Sabine Lange 
John Latham 
Athanasia Panopoulos 
Nicole Pinaire 
Joe Taube 
Regina Weaks 
Advisor 
Dr. Karen Vasquez 
Dr. Sharon Dent 
Dr. Stephanie Warowich 
Dr. Timothy McDonnell 
Dr. Michelle Barton 
Dr. David Johnson 
R. \V. (Bill) Butcher Achievement Award 
Established in 1977, the R. W. Bill Butcher Fund provides an annual award of $2,000 for a sntdem who 
demonstrates excellence in research, has a commitment to a career in biomedical research, and makes a 
professional contribution tO the community or has faced a particular challenge. This year's recipient is: 
Student Advisor 
Amber Johnson Dr. Michelle Barton 
Harry S. & Isabel C. Cameron Foundation Fellowship 
The Cameron Foundation provides a fellowship m an exceptional GSBS student working in research 
fields related to Alzheimer's or cardiovascular diseases. The Foundation gift of$10,000 is matched by the 
GSBS in 2006-2007 to provide a toml of $20,000 in stipend support to !he student. The 2006-2007 
recipient is Xi Mo, whose studies may lead to novel therapeuLics ro treat bleeding disorders as well as 
atherosclerosis and cardiovascular diseases. 
Student 
XiMo 
Advisor 
Dr. Renhao Li 
Alfred G. Knudson OutstaoPing Dissertation 
In 1997 an annual Alfred G. Knudson Outsmnding Dissertation Award was established by M. D. Anderson 
Cancer Cenrer ro honor this distinguished individual and former GSBS dean. The $1,000 award is given to 
a graduate of !he GSBS whose dissertaLion is selected as the most outstanding in cancer rese; 
year's recipient is: 
Student 
Ruoning Wang 
Advisor 
Dr. )ian Kuang 
stu£~ 
William W. and Pearl Wallis Knox Foundation Scholar 
Esr:~b lished in 2007, this is the fi rst year to award a Scholarship from the Knox Foundation, whose inter· 
ests arc research in the areas of AIDS and other infectious diseases in humans. This $2,500 award was 
presented to: 
Student 
Cana Ross 
Advisor 
Dr. Theresa Koehler 
City Federation of Women's Clubs Scholar 
Established in 2005, th is $2,000 Scholarship rewards an exceptional GSBS student who is working in an 
area vital to the biomedical sciences and of particular currem significance in that year's national research 
for this scholarship. For 2006-2007 this scholarship recognizes research in the axea of Stem Cells. 
Student Advisor 
Shannon Kidd Dr. Paul Simmons 
T. C. Hsu Endowed Memorial Scholarship 
To remember Dr. Hsu, and his remarkable research work, his daughter Margaxet, M. D. Anderson Cancer 
Center Foundation, colleagues, faculty, friends and former students of Dr. Hsu established this memorial 
scholarship in 2003. The scholarship is a living testimony and serves to acknowledge the stellar research 
accomplishments of graduate students focusing on his areas of research, genetics and cell bio logy. The 2006-
2007 recipient is Dung-Fang l ee, whose research studies will provide a more thorough understanding in 
inflammation -induced tumor development. 
Student Advisor 
Dung-Fang (Ben) Lee Dr. Mien-Chie Hung 
Rosalie B. Hite Fellow~ 
In 1946 Houston citizen Rosalie B. Hire left her entire estate ro establish a fellowship program for cancer research. This award includes 
a stipend of$25,000 per year, tuition and fees, and a single travel allowance up to $850 for each student to present his or her research at 
a national meeting. The 2006-2007 recipients are: Hannah Cheung (Dr. G il Cote, advisor), Yumin Hu (Dr. Peng Huang, advisor), 
Shannon Kidd (Or. Paul S immons, advisor) , Stephen Kry (Dr. Mohammad Salehpour, advisor) , Taichun Qin (Dr. Jean Pierre lssa, 
advisor). 
Presidents' Scholars 
Through funding from President James Willcrson, UT Health Science Center at llous· 
ton, and President John Mendelsohn, UT M. D. Anderson Cancer Center, rhis $5,000 
award is given to four advanced GSBS students who have demonstrated excellence in 
reseaxch. 
Student 
Ruoning Wang 
A thanasia Panopoulos 
Melissa Adams 
Stephen Kry 
Advisors 
Dr. ]ian Kuang 
Dr. Stephanie Watowich 
Dr. Phillip Carpenter 
Or. Mohammad Salehpour 
Michael Farley Moyers Heavy Particle Therapy Travel Endowed Award 
In 2006 GSBS Alumnus Michael F. Moyers, Ph.D. (1991/Horton) created this awaxd to provide travel support 
for an exceptional Medical Physics student who has had a paper accepted at the American Association of 
Physicists in Medicine (AAPM) to attend the annual meeting. Jonas Fonrenor received the Cameron Young 
lnvestig-.:~tor's Award from AAPM, and in rum is the first recipient of the Moyers Award of $500. 
Student Advisor 
Jonas Fontenot Dr. Wayne Newhauser 
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M.S. Category 
Student 
1st: Bahareh Tavana 
2nd: Rosanna lsaguirre 
3rd: Sara Spikes 
4th Violetta Chavez 
rds 
John P. McGovern, M.D., Scientific Poster Competion 
Advisor 
Or. Zahid Siddik 
Dr. Raymond Grill 
Dr. Gregory May 
Dr. Daniclle Garsin 
Thank you to our judges: 
Ph.D. Pre-Candidacy Category 
Drs. Joseph Alcorn, Hesham Amin, Diane Sick, 
Phillip Carpenter, Irma Gigli, Vidya 
Gopalaknshnan, Mtchacl Hallman, Constantin 
loannides, Theresa Koehler, Dina Lev, Shiaw-Yih 
Lin, Anita Mahajan, Hector Martinez-Valde.:, 
Osama Mawlawt, RaJagopal Ramesh, Georgto 
Rassidakis, Subrata Sen, Ana Tari, Robert Well , 
Yinhua Yu, and to Career Development presenter, 
Dr. Joya Chandra. 
1st: Sharon Way 
2nd Eliseo Castillo 
3rd Wade Kothmann 
4th Chris Singh 
Dr. Michael Gambello 
Dr. Kimberly Schluns 
Or. John O'Brien 
Dr. Chinnaswamy Jagannath 
Ph.D. Post-Candidacy Category 
1st: Yen-Michael Hsu tfts/1/fc Dr. Xin Lin 
2nd: Kimberly Manklewicz 
3rd: Brett Chiquct 
4th Charles Chung 
' 
Dr. Vasanthi jayaraman 
Dr. jacqueline Heche 
Dr. james Hixson 
.lllf'6 
tt "' I 
Dec S. & Patricia Osborne Endowed Scholarship in the Neurosciences 
Established by the Linda and Ronny Finger Foundation in 2001-2002, this endowed scholarship honors 
former University of Texas Health Science Center at Houston Development Board president, Dee O..bome 
and his wife PatTicia. Through the endowment an award of$1,000 is provided to the winning presenter in 
the graduate student category at the Annual Neuroscience Scientific Poster Session, and an additional 
SSOO ~tllormenc is given for travel for presentation at a scientific meeting. This award is presented during 
Brain Awareness Week. This year's recipient was: 
Student 
Feng Pan 
Advisor 
Dr. Stephen Massey 
Sam Taub & Beatrice Burton Scholarship in Vision Disease 
In 2004 this $2,000 award was establt hed by Mary Wright and her sister, Joanna Ross, in honor of their 
grandfacher and great aunt co support students with research in the area of sight-related vision problems, and 
the genetics and potential therapies behind these life-changing health concerns. The 2006-2007 recipient 
tS: 
Student 
Catherine Spellicy 
Advisor 
Dr. Stephen Dlliger 
Roberta M. & Jean M. Worsham Endowed Scholar!thip 
in the Behavorial and Neurosciences 
Formally presented during Bram Awareness Week this endowed scholarship of$1,000 fosters exceptional 
students working in the fields of the behavioral or neurosciences Wtth a focus on the areas of addict ion or 
obse~sivc/compulsive behavior. The recipient for 2006-2007 is: 
Student 
Aimee Lake 
Advisor 
Dr. Mark Bedford 
Graduate Student Education Committee at the Medical School Research Poster Competition: 
I t place: $400; 2nd place: $300; 3rd place: $200. 
First Place, Sharon Way (Or. Michael Gambello, advisor); Second Place ties: Wade Kothmann (Dr. John O'Brien, advisor) and Feng 
Pan (Dr. Stephen Mas ey, advisor); Third Place ties: Chris Wilson (Dr. Heinrich Taegtmeyer, advisor), Leslie Piggott , (Dr. Carmen 
Dessauer, advisor), Hanyin Cheng, (Dr. Robert Kirken, advisor), Kimberly Mankiewicz (Dr. Vansamhi jayaraman, advisor). 
m 
The Schissler Foundation Fellowships 
This dynamic family foundation has been a major benefactor to the Graduate 
School of Biomedical Sciences for over ten years and has sincere commit-
ment to the belief in graduate education. These fellowships foster collabora-
tion with the emphasis on basic science projects with a high likelihood of 
translational application to human health, and the requiremen~ that all stu-
den~ receive a broad ex-posure tO the biomedical sciences and ethical con-
cepts that underlie their research. This prestigious award, with the ever more 
directed focus on research studies wi ll continue to make significant contribu-
tions to the therapies and CLtres of common human disease through genetics. 
In 2006-2007 they have pledged rhree years of fu ll stipend and ruirion fu nding for 4 Schissler Foundation Fellowships with at least one 
expressly designated for a swdent working on cancer research with faculty at M. D. Anderson Cancer Center. The 2006-2007 recipi-
ents are: 
Schissler Foundation Fellows in the Genetics of Common H uman Diseases 
Student 
Andrea Lafom 
Yen-Michael Hsu 
Charles Chung 
Advisor 
Dr. Dianna Milewicz 
Dr. Xin Lin 
Dr. )arne Hixson 
Schissler Foundation Fellow in Cancer Research at M. D. Anderson Cancer Center 
Student Advisor 
Omar Duramad Dr. F. Xiao-Feng Qin 
Andrew Sowell, Wade Huggins Endowed Scholars, Professor and Fellow 
Cancer Answers/Sylvan Rodriguez Scholar 
The Andrew Sowell-Wade Huggins Scholars, Professor and Fellow along with the Cancer Answers/Sylvan Rodriguez Scholar represent 
the culmination of sixteen years of determined support and growth of the Cancer Answers charitable organization through rwo found-
ing mothers, Joann Sowell and Marcia Huggins Jahncke, their fami lies, cancer survivors, and comributing foundations including the 
Vivian L. Smith Foundation, Sylvan Rodriguez Charities, Bridgway Capital Managemem, and especially Bobby Sue Smith Cohn and 
Bo and Amy Huggins. Originally started as the fund raising entity to support the Andrew Sewell-Wade Huggins Endowment which 
generates all of these awards LO fu nd graduate education in cancer research, it has gained in size and prestige. Since 1991 a total of 48 
scholars and 3 sets of professor/fellow reams (renewable up m three years) have been honored with awards ranging from $2,500 up w 
$20,000 in stipend support. The 2006-2007 recipients include: 
Andrew Sowell-Wade Huggins Scholars 
Student Advisor 
Lmgchen Fu Dr. Richard Ford 
Yen Michael Hsu Dr. Xin Lin 
Dung-Fang (Ben) Lee Dr. Mien-Chie Hung 
Nicole Pinaire Dr.Timothy McD01mell 
Cancer Answers/Sylvan Rodriguez Scholar 
Stephen Kry Dr. Mohammad Salehpour 
Andrew Sowell-Wade Huggins 
Professor and G raduate Fellow 
Or. Gary Gallick and Jing Zhang 
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Student NEWS 
.,co7 .. oq GSA Officers Farewell (many thanks) .•. 
2006-2007 GSA Officers: 
Yen-Michael H su, Vice President 
MDACC. Molecular & Cellular O ncology 
Melan ie Dujka, President 
Pat Gibney, President, UTHSC 
Microbto logy & Mo lecular Genetics 
Brett Ch iquett, Vice President, UTI ISC 
Pediatrics MDACC, Immunology 
Violetta Chavez, Secretary 
UTHSC, Microbiology & Molecular Generics 
Nicole Pinaire, Secretary, MDACC 
Molecular Patho logy 
2007 Career Day for Students sponsored by the GSBS Alumni Association 
Career Development 
by 
Jon R. Wiener, Ph.D., Assistant Dean 
Academic Affairs 
Many students begin their education at graduate 
schools of biomedical sciences throughout the world with· 
out a clear plan for their career~. This is completely under· 
standable and even cxpccteJ. How can one prepare l1>ng· 
range career plans when rhey are just heginnmg to t''<pcri· 
ence research in a graduate school setting? 
Numerous survey~ indtcare that approxtmately 
80% of studen~ enter graduate biomedical science program~ 
with the expectation that they will eventually be a faculty 
member at a university. However, the data indicates th<\t 
approximately only 35% of studems eventually do become 
tenured or tenure-track faculty members by I 0 years post-
graduation. There i~ lhcrefore a considerable gap between 
early expectations and thl' rt•al world . 
The questiom all graduate schools in biomedical 
sciences should thus he asking themselves are: How are we 
preparing our students for the real work-world? How do we 
heir our students finc.l the niche they are best suited ior, 
and prepare them ro obrain the positions they seek? And, 
how early in their training should students be recei\'ing 
career development advice? 
Studen~ in the prc~ent era arc fortunate to be able 
to pursue varied awnu<.'s of ntrcer options, :>~ II of which arc 
viable for a career in the hinmedtcal sciences. Not only 
may sruden~ pursue academic faculty positions as they have 
for generations, but a:. wdl, they may pursue positions in 
indu5trial research, potent l.nv, scientific writing, tcchnol· 
ogy transfer, public pdicy, con~ulting, and sales, ro name a 
few, and with as much variety as maintaining a research 
career track with benchwl)rk, or becoming a medical llai-
~on, and never see the bench again. A generation ago, a 
choice of any option mhcr than academia w::~s considl'red 
'selling out.' Now it i:; consillercd not only wise to consider 
non-academic options, but indeed narrow-minded to not 
consider these possibilities, many of which have incrca~cd 
opportunities for ~clcmific: travel, nmuwn, and financial re-
muneration. 
Graduate schools must take on rhe responsibility 
to provide career development opportunities for their ~tu· 
denrs. Schools which 'bury their heads in the sand' and elect 
to nor provide cc.lucatiunalopponunities in career develop-
ment for rheir studen~ arc qu1te Simply liuuting the chances 
for their graduates ro become valued membe~ of the global 
biomedical community. Schools desire their graduates ro 
succeed, not on ly tu briug regard to the school as a Jisrin· 
guished graduates, hut also to assisr in the recruirment nf 
the next generation of scientists, and ro bring in develop· 
mcnt funds to assist the training of present and future stu-
dents. In this golden ::~ge of biomedical science, all schools 
must assist their students in seeking, finding, and preparing 
for positions in all the vari<.·d career choices that are now 
a\'ailable to them. 
The GSBS, as a part of the UT Health Science 
Center at Houston, in partnership with the UT M.D. Ander· 
~n Cancer Center, endeavor" to provide career devclnp-
ment training for GSBS students. A combination of week· 
end workshops, career fairs, and a full seminar series has al-
ready been set up. In add1t1on, the GSBS Alumni Associa· 
tion has developed an 'c-mentoring' program, an extremely 
valuable on-line resource that matches current students with 
alumni from the GSBS who work m various careers in rhe 
biomedical sciences, in <ln effort to provide ~tudents with 
real-life advic.:t on the cmeer:. they are considering. Many 
of these alumni also speak ar the Annual Career Fair. Check 
It out at~ 
http://gshs.uth.tmc.edu/alumnVinreach_pamcipanrs.html 
Finally, we arc always thinking of ways we can adJ 
more opportunities for the students to learn ahout their ca-
reer options. Students should avail themselves of all of these 
resources, and begin doing so early in their training, to ac-
quire the. information they need to make wise career choices. 
STAR TEAM 
OurGSBS Staff was presented with The University of T exas 
H ealth Science Center at H ouston Star T eam Award and 
$5,000 to benefit the Staff anJ School. "The Three Muske-
teers philo ophy-all for one anti one for all" and a willing-
ness to go the extra d istance for :.tudenrs, faculty and com-
munity made the difference. Here left to right: Gina 
C happell, Brenda Gaughan, Lily D'Agostino, Jeannice 
Theriot, Carol He lton, Alice Hatcher, Linda Carter, Bunny 
Perez, Angela Doggett, Michae l Valladolid, Tom Goka, 
Vicki Knutson, Heidi Porter, Liz Stamey, T y Williams, 
Cheryl Spitzcnberger, Mary Yehle, Karen Weinberg, Jon 
Wiener, Paul Darlington. 
LEADERSHIP /\WARD 
Paul Darlington, Ph .D., Associate Dean 
of the GSBS, received the 2007 Michael 
J. Jimenez Leadership in Action Award 
from UT-Health Science Center. This 
award was established in memory of the 
late Mike Jimenez, former vice president 
and chief human resources officer at the 
UT Health Science Center. It is given 
for demonstrating a commitment to collaboration and pro-
ductive re lationships with facu lty and staff at all levels of 
the organization; energy and enthusiasm for the work of the 
univer·iry; a consistently po itive attitude; and a commit-
ment to do the right thing. 
Melva S. Ramsay AWARD 
Carol H elton, Administrative Assis-
tant for Finance and Per onnel, is , 
the 2007 recipient of the GSBS 
Melva S. Ramsay Award for out-
standing service to faculty, rudents, 
and staff. The award of $500 (and 
flowers) is presented by Geo rge 
Stanccl, dean of the GSBS. 
Staff NEWS 
Distinguished Visitor 
President James Willerson, Dean George Stance!, and 
Minister of Education and Training of Vietnam, Professor 
Nguyen Thien Nban, is being presented here with a 
photo of the Houston Texas Medical Center. 
Hellooo . . . NEW GSBS STAFF 
Joy Lademora has joined the team in the 
Academic Affa irs Office and assists Deans 
Jon Wiener and Thomas Goka. joy re-
ceived her M.S. from the University of Ma-
nila and is newly married after moving here 
from the Phill ipines. Her favorile hobby is 
volleyball where she is a seri ous center 
spiker. 
Michael Valladolid is our new IT Systems 
and Applications Specialist. Mike gradu-
ated from the University of Delaware, i 
married <md keeps busy (when. be's not at 
GSBS) with his wife, 18 month o ld son, and 
two dogs. For reh-1xarion he takes long walks 
on the beach. 
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Distinguished Alumnus 2006 .. 2007 
John J<opchick, Ph.D. 
Growth Hormone, Mice, Football, Dirty Shorts and a New Drug 
I am still amazed that a molecule secreted by the 
pituitary gland, namely growth hormone (GH), directs both 
anabolic and catabolic processes. This is best seen when 
recombinant G il is administered to growing pigs wherein 
one observes a decrease in fat, and an increase in bone and 
muscle. What a wonderful molecule! These observations, 
made in the early 1980s, may have been somewhat ordinary 
co a physiologist, but were quite remarkable to a molecular 
biologist, in particular me! It started my scientific path of 
attempting to de£ine the molecular mechanism(s) of GH 
action. We arc still attempting to do this. 
One simple-minded concept that could account 
for the multiple activities of G H was co hypothesize that 
the molecule had different "domains• and chat these do· 
mains were responsible for the various activities of the hor-
mone. This was our thought process in the mid 1980s. We 
set out co test this hypothesis by performing structure/func-
tion studies. Basically, we changed G H's structure and 
determined the affect on function. These altered GH mol· 
ecules were collecttvely termed GH analogs. 
It was the widely held opinion among endocrinolo-
gists that if one were to change the structure of a peptide 
hormone, those changes should result in altered interac· 
tions or binding properties of the molecule to its cognate 
G H receptor. Although l believed chis basic maxim and 
performed the classical in vitro receptor binding studies, I 
also thought that a cell based or in vivo reporter system ulti· 
mately would generate additional information concerning 
the molecule's activity. This is where transgenic mice come 
into play. 
Mice that possess and express extra copies of G I-l 
genes (GH transgenic mice) are larger than their nonnal, 
non-transgenic siblings. We decided to study the activity 
of the G H analogs in vitro using classic receptor binding 
protocols and in vivo via growth enhancement of transgenic 
mice. Thus, we would change the GH molecule via amino 
acid substitutions or deletions, isolate the altered hormones, 
perform GHR binding studies, and generate transgenic mice 
that expressed the mutated DNA encoding the GH ana-
logs. We expected that as the in vitro binding of the G H 
analogs LO the GHR decreased, a corresponding loss of 
growth enhancement in the transgenic mice would occur. 
This was indeed the case for many of the G H ana· 
logs. (By the way, G H possesses 191 amino acids and we 
have changed nearly all of them). 
I now need to describe G H in terms of its topology. 
The crystal structure of the molecule has been solved and 
shows that it contains four a.-helices. a-helix number 3 has 
amphipathic characteristics, that is, the charged or hydro-
philic amino acids are separated from the non-polar or hy-
drophobic amino acids. However, there is one hydrophilic 
amino acid in the "sea" of hydrophobic residues, and one 
hydrophobic am ino acid and a glycine residue in the hydro· 
philic area. O ne of our first alterations was to change these 
three amino acids in the third a.-helix to make the molecule 
a "perfect" amphtpathic a.-helix that is, an a.-helix with a 
complete hydrophobic domain juxtaposed to a full hydro-
philic area. In doing this, we anticipated that we would 
increase the activity or potency of G H with high expecta· 
tions of generating a molecule that would bind to the G HR 
with higher affinity than native GH and that would gener· 
ate "really big mice." 
If one expects a molecule to be more potent in its 
biological activities than the original molecule, the dogma 
of the pharmacology would predict that it should interact 
with its receptor "better." When we performed the experi· 
ments, we found that this "perfect" G H analog bound to 
GHR with the same characteristic as normal GH; it did 
not bind with higher affinity. We were terribly depressed 
with these resulLS and were ready to "throw it our." Fortu· 
natcly, we were so convinced that this perfect third a.-helix 
should possess an altered activity that we generated the cor· 
responding G H ana log transgenic mice. T o our surprise, 
instead of generating a giant mou e, we obtained a small 
mouse. In fact, it was approximately one-half the size of 
normal mice. We have affectionately named this mouse 
"Mini." (We aren't very original, are we?) We went on to 
how that chis molecule was acting as a classic antagonist. 
This was the first description of a large protein antagonist 
and certa inly the first G H antagonist. 
We subsequently changed these three amino ac-
ids, one at a rime, and found that it was not the three changes 
but only the glycine at position 120 in human Gil that was 
W1lportant for the activity of the molecule. When this gly-
cine, located ncar the middle of the third a.-helix, was 
changed to any other amino acid other than alanine, a G H 
molecule that inhibited growth was generated. Thus, one 
amino acid change out of 191 converted GH from a growth 
promoter to a growth suppressor or a GH antagonist. 
From my years in the pharmaceutical industry, it 
was "drilled' into my subconscious that anything that inhib-
ited a physiological process in vivo could be of potential value. 
For example, there are many instances of drugs that inhibit 
enzymatic activity or those that inhibit hormonal action. 
Since we discovered a GH antagonist, i.e. a molecule that 
inhibited GH action, I thought that it might have clinical 
value. After many hours in clinical libraries, I came up with 
three potential uses for a GH antagonist: for the treatment 
of acromegaly, diabetic end organ damage, and certain types 
of cancers. I quickly wrote a proposal in which l described 
the discovery and use of the GH antagonist. After submit-
ting the proposal to just about all of the large pharmaceuti-
cal companies and giving numerous presentations on the 
discovery and potential uses of the GH antagonist, I was 
somewhat depressed (again!!) in that there were no "tak-
ers." Two large companies expressed some interest in the 
GH antagonist for the treatment of diabetic end organ dam-
age, but none were interested in acromegaly, a condition 
caused by pituitary tumors that secrete GH. 
I took out my frustrations concerning the lack of 
interest of the pharmaceutical industry for GH antagonists 
by performing physical exercise, especially with the Ohio 
University football coaches. They put me through some 
very agonizing drills. One of the coaches, the late Joe Dean, 
would routinely ask what I was doing in the laboratory. As 
we were straining on a weight lifting machine, I happened 
to tell him that we had discovered a potential drug but no 
one was interested. He relayed to me that one of his former 
students and football players, Richard Hawkins, knew "some-
thing about drugs." Rick was founder and CEO of a drug 
development company called Pharmaco, Inc. Joe scribbled 
Rick's phone number on a piece of scrap paper and said that 
I should give him a call. Frankly, I misplaced the number 
with my soiled workout clothes. Luckily, my wife found the 
wrinkled and "clean" piece of paper in the washing machine. 
Several days later when in the process of writing 
an NIH proposal and day dreaming, l decided to call Rick. 
After an enjoyable conversation, he asked me to send him 
my proposal concerning the discovery and use of the GH 
antagonist. I sent it to him by overnight mail. About one 
week later, he called and asked why I did not send him the 
proposal. 1 said that l had. He subsequently found it on his 
desk in one of the many mountains of paperwork. That 
night, during a bout with insomia, Rick proposal 
and as he recounts, "could not sleep the remainder of the 
night." He was incredibly excited about the GH antagonist 
and potential uses, especially for acromegaly. Now, we had 
two individuals excited, Rick and me. 
Rick, John Scarlett {a friend of Rick's) and I formed 
a company called Innovations in Drug Development whose 
name was subsequently changed to Sensus, a virtual com-
pany that out sourced all of its developmental resources. 
There was a small but extremely dedicated and competent 
group of individuals within Sensus who shou ld be commended 
for the development of the GH antagonist along with the 
many clinicians who perfonned the clinical trials for acrome-
galic individuals. The data shows that the GH antagonist 
was efficacous in -90% of these patients. The FDA is now 
reviewing the data. Pham1acia Corp. will market the drug, 
now called Soma vert (pegvisomant for injection), if and when 
it is approved. Hopefully, it will also be tested for other indi-
cations including cancer and diabetic end organ damage. 
Thus, a combination of unanticipated scientific re-
sults, coupled with several serendipitous social events ulti-
mately resulted in a new drug that will benefit many indi-
viduals. 
There could be many take home messages from this 
story but the two I like best are: "Be careful not to throw out 
the phone number with the wash" or "Football coaches can 
be smart!!!! " 
*I would like to acknowledge everyone who contributed to 
the discovery and development of GH antagonists. The list 
is formidable, however, I'd like to particularly acknowledge 
Wen Chen, Nick Okada, Tim Coleman, Joe Dean, Rick 
Hawkins, John Scarlett, Peter Trainer and all of the other 
clinicians who performed the clinical trials, Lawrence and 
Milcon Goll , and Ohio University. 
**This story is dedicated to the memory of]oe Dean. 
John J. Kopchick, Ph.D. is the Goii-Ohio Professor of Mo-
lecular Biology at Ohio University. Also, he is head of the 
Growth, Obesity, and Diabetes group in the Edison Biotech-
nology Institute as well as Professor in the Biomedical Sci-
ences Department in the College of Osteopathic Medicine 
at Ohio University. 
"Mini Mice, Football, and Dirty Shorts" John J. Kopchick, 
The Endocrinologist: Autumn 2001, Number 61, 13. 
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GSBS ALUMNI REUNION 2006-2007 
Alumni East Coast Reunion 
The University of Texas 
GSBS Alumni 
2006 Reunion 
Leposava Antonovic 
Richard Bartlett 
Yanis Boumber 
Valentine Goodrich &}\ling 
Joan Breuer McHam 
I vone BrLu10 
Joya Chandra 
Vicky Estrera 
Siqing Fu 
Tom Goka 
Maureen Goode 
Richard Hajek 
Julie Harless 
Peng Huang 
John Kopchick 
Joshua Krumenacker 
Xiaotao Li 
Joy Marshall 
Milton Marshall 
Shirlette Milron 
Catherine Moya 
Jennifer Newcomb-Femandez 
Bay Van Nguyen 
Karen Niederreither 
J iangong N iu 
Mustafa Ozen 
Jacqueline Peltier Horn 
Mary Riser 
Zheng (Jane) Shi 
Cynthia Skinner-DeBord 
Ben Thomas 
Deidre Vedder 
Brenda Whaley 
David Wildrick 
Thomas Wood 
Kendra Woods 
Wan-Song Wun 
Jianhua Yang 
Dihu<t Yu 
Hong Zhang 
You 1nd <1 Guest .a~ lnvired to •n •..usembfy" 
.. 
flw.Uni\1!Uily(/.T~ 
u~ 5diCd d. Siomcdiul Scien<:~ a1 1-biMon 
East Coast Alumni 
,Or 'llriti'W'I( ~ ll'le lMif'\1: GS8S N~ Mid V..W. 
olndDitllll!'fM.theSbo.d\~M!t 
Ucla Anestidou 
Elizabeth Bruckhcimer 
Cherie Buns 
Tsung-Cheng Chang 
'Chi-Ping Day 
Sandeep Dayal 
Zuoming Dcng 
Stephen Hewitt 
Howard Hubbell 
Raegan Hum 
Lingxia Jiang 
Jeffrey Kiefer 
Gene Lang 
Saturd3y, Juoo 1 &. 2007 
Mercedes Meyer 
Sana Pratt 
Joye Purser 
Ashurosh Rao 
Ana Robles 
Thomas Roesel 
Travis Vaught 
Simon Will iams 
Virginia Wray 
Wayne Wray 
Monica Zamisch 
Jean Claude Zenklusen 
Alan Z<lrrinneshan 
news flash 
Geetha Achanta, Ph.D. (2004) is a science communicator 
for the Internationa l Nutrition Compan y BY, a 
neutriceutical company in The Netherlands. 
Gabriela Bowden, Ph.D. ( 1999) (Reuters) published in the 
journal Science, led a study of the toxic Staphylococcus aureus 
bacteria and noted that it can pass one another the gene for 
the toxin Panton Valentine leukocidin (PVL) which itself 
causes pneumonia. 
Understandi ng that could provide a way to develop new 
drugs or vaccines and shed light on how bacteria acquire 
new and dangerous quali ties. 
D awn Chandler, Ph.D. ( 1998) is a new assistant professor 
in the department of pediatrics and the center for child-
hood cancer at O hio State University, Columbus, O H. 
Keith Chan, Ph.D. (2004) postdoctoral fellow at Stanfo rd 
University was just awarded his first NCI K99 grant. 
Antonio Chiocca, M.D.,Ph.D. ( 1998) neurosurgeon at 
Ohio State University Medical Center for both research and 
chnical activities in both surgery and cancer care has been 
selected to receive the 2007 Grass Prize in Neurosurgery. 
Vicky Estrera, Ph.D. (2001} is the PI for a new NIH MARC 
(Minority Access to Re:.earch Careers} grant of $300,000 
over five years at the University of Houston-Downtown. 
This grant will bring five o r six students a year to GSBS for 
summer research with the potential of becoming GSBS stu-
dents upon graduation. Fellow alumni and GSBS assistant 
dean for minority affairs, Thomas Goka, Ph.D. (1974) will 
work with Dr. Estrera to coordinate the summer program. 
Valentine Goodrich-Boving, Ph.D. (1969) nominated in 
memory, T . C. llsu, Ph.D., for a conference room at Sigma-
Gcnosys, Woodlands, TX biotech firm. Dr. Boving is newly 
appointed as S r. Improvement Advisor in C linical Opera-
tions at UT-M. D. Anderson Cancer Center. 
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Ronald Harwerth, Ph.D. ( 197 L) currently a University of 
HoustOn professor, received the American Academy of 
OptOmetry's Charles F. Prentice Medal Award. 
Leslie H odges-Gallagher, Ph.D. (2002) started a new posi-
tion as Director of Molecular biology at Combithera, a new 
biotech company developing products that combine small 
molecule signaling inhibitors with endocrine therapies for 
hormone-related cancers. 
Elizabeth Oldham Hileman, Ph.D. (2003} newly appointed 
to Project Director a UT-M. D. Anderson Cancer Center's 
External Collaborations office of Technology Discovery. 
Dorrie Lamb, Ph.D. ( 1980) was recently appointed to the 
Lester and Sue Smith C hair in Urologic Research at Baylor 
College of Medicine (BCM). According to another GSBS 
alumni, T imothy Boone, M.D., Ph.D. (1985) and award-
winning head of the uro logic department at BCM, "Dorrie 
has built a world class laboratory and her mentorship to 
young invesligators is a shining example to the entire 
college." 
Hui-Wen Lo, Ph.D. ( 1994) is a new assistant professor in 
the division of experimemal surgery at Duke University 
Medical Center, Durham, NC. 
Pierrette Lo, M.S. (2002) joins Texas Heart Institute as a 
scientific writer. 
Maribelis Ruiz, Ph.D. (2003) re-located as medical science 
liaison for Abbott Laboratories in San Juan, PR. 
Shankar Sellappan, Ph.D. (2005) While at Frost & Sullivan 
has received a license (parent award) on his use of the LICOR 
Biosciences' Odyssey System, in large part as a result of his 
work as a GSBS student while in the lab of Dihua Yu, M.D., 
Ph.D. ( 1991) alumni and UT -M. D. Anderson faculty mem-
ber. T his mechanism opens up new avenues for protein ex-
pression research. 
Aurora Seminara, Ph.D. (2005) is the new Scientific Di-
rector at ProHealth, a division of Draftfcb Healthcare in 
New York. 
Zheng (Jane) Shi, Ph.D. (2001) is a patent agent and at-
tending law school. 
Debra Wallis, Ph.D. ( 1999) opened a coffee shop and ca-
tering business "Central Perks" in Marshall, TX. 
Kendra Woods, Ph.D. (1995) during UT -M. D. Anderson's 
Cancer Center partnership launch met with their Royal Jor-
danian Highnesses Ghida and Dina in Amman, Jordan, and 
mo t recently Pre ident and Mrs. George Bush. 
Wanting (Allison} Xu, Ph.D. (1999) is assistant professor, 
Diabete Center and the Department of Anawmy, Univer-
sity of California, San Francisco. 
Tom Piantanida, Ph.D . (1972) 
"I've hcen involved in color vision ge-
netics, and in fact shared the Newcomb-
Cleveland Prize from AAAS for se-
quencing the genes that encode the hu-
man color-vision pigments. I had a nice 
career al SRI where the philosophy was that I could do 
anything I wanted to Jo, as long as I could find some-
one ro pay for it. So, I worked in stabilized-image re-
search, invented a non-invasive intracranial pressure 
mom tor, a telemetry SID$ monitor, researched the "fill-
ing-in" mechanism, whtch keeps us from seeing our own 
hlindspor-it d()C:) much more than that, and it is criti-
cal to stercmcopic vision-and I started a virtual reality 
lah to research the perceptual effects of VR technol-
ogy. 
When I tarred GSBS, one of my Professors - Bob 
Benolken, as I recall • to ld me that the purpose of the 
Core Program was to prepare any GSBS Graduate to 
hold up hts end of a conversation at a cocktail parry at 
Cambndge. That "generalbt" attitude has provtded 
me with more than a few research prOJects over the 
years. And, yes, tt has enabled me to converse with a 
wide v,uiery of scientists, sometimes drawing on tid-
hits gleaned from the Core Program." 
5 P ECI A l thanks. and gratitude September 2006-Jufy 2007 
Leader Cullen Trust for Higher Education 
Cullen Trust for Higher Education made this record Leadership gift of $1,115,000 to the Graduate School for the 
putpose of underwriting its M.D./Ph.D~ program. Organized through the GSBS, the gift provides dramatic growth 
opportunities for students in the program at UT~Houston MediCal School, UT,M. D. Anderson Cancer Center1 and 
the Baylor College of Medicine Graduate School of Biomedical Sciences. 
Our Benefactors Our Donors 
The Blackwell Foundation Greg Aune Stephen Hewitt Melissa Aldrich Beng and Dah Hsi Ho 
Cancer Answers, Inc. john Amolak Kenneth Hegstrom 
Harry S. & Isabel C. Frances Arrighi G lenn Housholder 
Cameron Foundation Michael Badzioch Jen-Tza Huang Michelle Barton Mien-Chie Hung 
Mimi Cho,Rohlfsen Caro l Blanchard Gary Johanning 
S. Stacy Eastland Timothy Boone Faye Johnson 
Irma Gigli Paul Borchardt Jeffrey Johnson 
Yanis Boumber Daniel jones David M. Grimes II Valentine Boving Hitesh Kapadia 
George Ann Harding Joan Breuer-McHam Norman Karin 
Diana Hawkins L. Maxmilian Buja Robert Kirken 
Margaret Hsu William Butcher W illiam Klein Daniel Carson James Knierim 
Geoffrey Ibbott Linda Carter Ralf Krahe 
Rodney Kellems Roberr Chamberla in Zvonimir Krajcer 
Robert W. & Pearl W. Stacey Champion Robert Ku 
Knox Foundation Shine Chang M. Tien Kuo Tse-Chang C heng John Kurland 
John Kopchick Esther Cheung Gary Kurzban 
Anand Lagoo Madelene Coombes Richard Lane 
Sandhya Lagoo- Gilbert Cote Matthew Lawrenz Quita Cruciger George Leventon Deenadayalan Stephen lf<~iger Xin Lin 
Fred & Marilyn Lummis Peter Davies Yun Lin 
Kevin Morano Zuoming Deng Carol Linsner 
John P. McGovern Carmen Dessauer Pu Liu Donna DiPaolo Kathryn Louie 
Foundation Herbert Dupont Karen Lu 
Peggy O'Neill Jul ie Ellerhorst Tom & Nancy Matney 
John Powers Cindee Ewell Beth Lynn Maxwell 
Melva Ramsay Frank Fasullo Pierre McCrea Isaiah Fidler Richard Meisch 
Randall Rupp Ralph Freedman Marvin Meistrich 
The Schissler Foundation Rhonda Friedbert Raymond Meyn 
Joel Staff Jeffrey Frost Shirlen e Milton Yasuhide Furuta Yuko Miyamoto 
Douglas Stickle Gary Gallick & Jan Liang Radhe Mohan 
Karen Storthz Brenda Gaughan Kevin Morano 
Ralph Thomas Eugene Gerner Debra Moss 
Deidre Vedder Armand G lassman JoAnn Moulds Millicent Goldschmidt Shahla Nader Eftekhari 
Danny Welch Jason Goldsmith Jennifer Newcomb-
Tom & Mary Ruth Siew-Ging Gong Fernandez 
Williams Yi-Zhong Gu Sarah Nobl in 
Jean & Roberta Worsham James Gum Hope Northmp Dianne Hammond Grier Page 
Wan-Song Wun Steven Hanks Nickolas Papadopoulos 
WeiYu Carol Helton T ed Pate 
Project GRAD 
Project Grad founder Mr. James Ketelson and his wif~ Kathryn (not shown), 
along with representatives of The Favrot Fund, Mr. Lenoir Josey II, Lenoir Josey 
Ill, and Mr. James Calaway listen to a student journal reading about the morning's 
experiment of isolating DNA. For the past three years GSBS has been selected 
to provide a two-week hands-on biomedical sciences seminar for Project Grad 
participants. The Project Grad Seminars at the GSBS is directed by Dr. Tom 
Goka, Assistant Dean of Outreach and Minority Affairs. 
Sen Pathak 
Deborah Pearson 
Jacquel ine Peltier-Hom 
Berty Petrie 
Heidemarie Porrer 
Karl Prado 
Janet Price 
Usman Qazi 
Donna Reeve 
Ellen Richie 
T homas Roesel 
Aaron Roome 
Joyce Rundhaug 
Jeffrey Safran 
Barbara Sanborn 
Priscilla Saunders 
William Schull 
Stanley Schultz 
Leanne Scott 
Robert Shalek 
Bardett Sheinberg 
Donna Sheach 
Zheng Shi 
Ann-Bin Shyu 
Malcolm Skolnick 
Ani l Sood 
Cheryl Spitzenberger 
George Srarkschall 
James Strong 
Gulnar Su(Veyor 
Heimich Taegtmeyer 
Ming Tang 
Ba-Bie T eng 
Jeannice Theriot 
Chadwick Thompson 
Janet T ravis-Davis 
Ah-Lirn Tsai 
Kishor Wasan 
Brenda Whaley 
Barbara Williams 
Li-Hua Wong 
Kendra Woods 
Virginia Wray 
Willy Wriggers 
Pamela Yang 
Edward Yeh 
Mary Yehle 
Dihua Yu 
}ing-Ren Zhang 
Wei Zhang 
Leonard Zwelling 
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Hello Everyone, 
This is my favorite time of year, the end of the academic year and the most important event, Commencement is now 
behind us! After all of the effort, sacrifice, placing other aspects of life on hold to focus on research and writing, let the 
celebrations begin! Once friends and family saw our GSBS graduates cross that ever important stage to the joy and 
pride of their faculty mentors they somehow understand just how powerful the joumey has been. I love the pageantry, the 
tradition and I stand ready to join the party. Over 50 students crossed the stage with 50+ more celebrating in spirit from 
their various new postdoctoral, pharmaceutical and Nil I positions. 
To celebrate both students and alumni the Steering Committee organized several activities. First, we welcomed the 
2006-2007 graduates into the official ranks of the GSBS Alumni Association with a final Friday Aftemoon Club (on 
Thursday, May 3). Later, in June, we continued the tradition set last year of a great West Coast Reunion by hosting the 
first ever East Coast Alumni Reunion on June 16 in Washington D. C. Thirty~ intrepid alumsjoumeyed to Georgetown 
for a wonderful evening and GSBS update. Our annual alumni-sponsored Career Day for GSBS students took place later 
in June with 12 alumni speakers showcasing their professional expertise and stellar careers in areas which our students 
indicated the desire to learn more. Thank you especially to Alumni Stars Russell Broaddus, M.D., Ph.D. ( 1994); Randy 
Evans, Ph.D. (2002); Deanna Leonard, Ph.D. (2002); Janci Chunn Lingsay, Ph.D. (2006); Milton Marshall, Ph.D. (1975); 
Darren Woodside, Ph.D. ( 1998), David Wooten, Ph. D. ( 1998) and the Alumni Steering Committee. 
I have had the privilege this year to have worked with a dedicated and innovative group of Alumni Steering Commit-
tee members: past presidents Joya Chandra, Ph.D. ( 1998) and Dorrie Lamb, Ph.D. ( 1980); vice president Ben Thomas, 
Ph.D. (1973); Vicky Estrera, Ph.D. (200 1); Maureen Goode, Ph.D. (1985); Mustafa Ozen, Ph.D. (1999) and our newest 
member Joy Marshall, Ph.D. (2003). These GSBS alumni have enthusiastically devoted their time to make the 2006-
2007 academic year extraordinary. 
One final note and celebration to consider, our Distinguished GSBS Alumna for 2007-2008 is Dr. Suzanne Fuqua 
( 1982/Naso) noted for her pioneering work on hormonal resistance in breast cancer. The Alumni Reunion in llouston is 
scheduled for the evening of Friday, October 19 so plan now to celebrate with me. 
Cheers, 
'i~d.-A... 'V. t0oc&:, ,.P~. D. 
Kendra Woods, Ph.D. (1995) 
GSBS Alumni Association President 
2006-2007 
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